SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD
SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD (China) holds 2 active US FDA Type II Drug Master Files. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shanghai-basalmedia-technologies-co-ltd
Overview
SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering CELL CULTURE MEDIA; DISSOCIATION MEDIA.
API / Drug Master Files
SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- CELL CULTURE MEDIAActive2023-11-28
- DISSOCIATION MEDIAActive2023-02-20
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this SHANGHAI BASALMEDIA TECHNOLOGIES CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.